Enlivex Therapeutics Ltd. — Investor Relations & Filings
Filings indexed
379
across all filing types
Latest filing
2026-05-28
Regulatory Filings
Country
US
United States of America
Listing
US
ENLV
Enlivex Therapeutics Ltd. is a clinical-stage company developing macrophage reprogramming immunotherapy. Its primary focus is the development of Allocetra™, a universal, off-the-shelf cell therapy designed to rebalance immune hyper-responses. The therapy aims to modulate macrophages as a therapeutic strategy against inflammatory diseases. Enlivex is evaluating Allocetra™ for multiple indications, including acute inflammatory conditions like sepsis and chronic inflammatory diseases such as osteoarthritis. The product offers flexible administration options, including systemic intravenous infusion and targeted local injections, and has been administered in clinical trials to over 250 patients with no reported drug-related serious adverse events.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-28 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-27 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-18 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-15 | English | |
| 6-K - Enlivex Ltd. (0001596812) (Filer) | 2026-04-21 | English | |
| 6-K - Enlivex Ltd. (0001596812) (Filer) | 2026-04-08 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47859677 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-28 | English | ||
| 47518294 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-27 | English | ||
| 46384758 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-18 | English | ||
| 46362365 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-15 | English | ||
| 34766214 | 6-K - Enlivex Ltd. (0001596812) (Filer) | 2026-04-21 | English | ||
| 33814097 | 6-K - Enlivex Ltd. (0001596812) (Filer) | 2026-04-08 | English | ||
| 33048678 | 6-K - Enlivex Ltd. (0001596812) (Filer) | 2026-03-26 | English | ||
| 33040031 | 20-F - Enlivex Ltd. (0001596812) (Filer) | 2026-03-25 | English | ||
| 33040001 | 6-K - Enlivex Ltd. (0001596812) (Filer) | 2026-03-25 | English | ||
| 33032354 | 6-K - Enlivex Ltd. (0001596812) (Filer) | 2026-03-24 | English | ||
| 33013111 | 6-K - Enlivex Ltd. (0001596812) (Filer) | 2026-03-23 | English | ||
| 33001982 | 424B3 - Enlivex Ltd. (0001596812) (Filer) | 2026-03-20 | English | ||
| 19423449 | 6-K - Enlivex Therapeutics Ltd. (0001596812) (Filer) | 2026-02-10 | English | ||
| 30804306 | 6-K Filing | 2026-02-05 | English | ||
| 30804284 | 6-K Filing | 2026-01-26 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
|
AB Science
Researches and develops protein kinase inhibitors for human…
|
AB | FR | Manufacturing |
|
ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, …
|
ABVC | US | Manufacturing |
|
ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS diso…
|
ACAD | US | Manufacturing |
|
Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for…
|
950130 | IN | Manufacturing |
|
Accretion Nutraveda Limited
Develops and manufactures pharmaceutical, nutraceutical, an…
|
544694 | IN | Manufacturing |
|
Accretion Pharmaceuticals Limited
Develops and manufactures therapeutic formulations across d…
|
ACCPL | IN | Manufacturing |
|
Acerus Pharmaceuticals Corporation
Specialty pharmaceutical company focused on developing and …
|
ASPCF | CA | Manufacturing |
|
ACHIEVE LIFE SCIENCES, INC.
A late-stage pharmaceutical company developing a treatment …
|
ACHV | US | Manufacturing |
|
Achyut Healthcare Limited
Procures, trades, and manufactures pharmaceutical APIs and …
|
543499 | IN | Manufacturing |
Enlivex Therapeutics Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34882/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34882 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34882 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34882 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34882}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Enlivex Therapeutics Ltd. (id: 34882)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.